IL117727A - Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them - Google Patents

Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them

Info

Publication number: IL117727A
Authority: IL; Israel
Prior art keywords: pharmaceutical compositions; compositions containing; hiv activity; synergistic combinations; synergistic
Prior art date: 1995-03-30

Application number

IL11772796A

Other languages

English (en)

Other versions

IL117727A0 (en

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-30

Filing date

1996-03-29

Publication date

1999-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL117727(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-30 Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en

1995-03-30 Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en

1996-03-29 Application filed by Wellcome Found filed Critical Wellcome Found

1996-07-23 Publication of IL117727A0 publication Critical patent/IL117727A0/xx

1999-11-30 Publication of IL117727A publication Critical patent/IL117727A/xx

Links

230000036436 anti-hiv Effects 0.000 title 1
230000000694 effects Effects 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
239000011885 synergistic combination Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Virology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicinal Preparation (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Cephalosporin Compounds (AREA)

IL11772796A 1995-03-30 1996-03-29 Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them IL117727A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9506490.3A GB9506490D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
GBGB9506489.5A GB9506489D0 (en)	1995-03-30	1995-03-30	Antiviral combinations

Publications (2)

Publication Number	Publication Date
IL117727A0 IL117727A0 (en)	1996-07-23
IL117727A true IL117727A (en)	1999-11-30

Family

ID=26306774

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11772796A IL117727A (en)	1995-03-30	1996-03-29	Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them

Country Status (35)

Country	Link
US (1)	US6417191B1 (fr)
EP (1)	EP0817637B1 (fr)
JP (1)	JP2954357B2 (fr)
KR (1)	KR100542536B1 (fr)
CN (1)	CN1103593C (fr)
AP (1)	AP652A (fr)
AT (1)	ATE220551T1 (fr)
AU (1)	AU715213B2 (fr)
BR (3)	BRPI9607851B8 (fr)
CA (1)	CA2216634C (fr)
CZ (1)	CZ295940B6 (fr)
DE (3)	DE122005000029I2 (fr)
DK (1)	DK0817637T3 (fr)
EA (1)	EA000626B3 (fr)
EE (1)	EE04047B1 (fr)
ES (1)	ES2179193T3 (fr)
FR (1)	FR05C0022I2 (fr)
GE (1)	GEP20022647B (fr)
HU (1)	HU224010B1 (fr)
IL (1)	IL117727A (fr)
LU (1)	LU91171I2 (fr)
MX (1)	MX9707316A (fr)
MY (1)	MY115461A (fr)
NL (1)	NL300195I2 (fr)
NO (2)	NO313787B1 (fr)
NZ (1)	NZ306419A (fr)
OA (1)	OA10616A (fr)
PL (1)	PL187085B1 (fr)
PT (1)	PT817637E (fr)
RO (1)	RO117995B1 (fr)
SI (1)	SI0817637T1 (fr)
SK (1)	SK283825B6 (fr)
TR (1)	TR199701074T1 (fr)
UA (1)	UA60293C2 (fr)
WO (1)	WO1996030025A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ333099A (en) *	1996-06-25	2000-06-23	Glaxo Group Ltd	synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
US6113920A (en) *	1996-10-31	2000-09-05	Glaxo Wellcome Inc.	Pharmaceutical compositions
TW536403B (en) *	1997-03-24	2003-06-11	Glaxo Group Ltd	An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) *	1997-05-17	1997-07-09	Glaxo Group Ltd	A novel salt
BR9809127A (pt) *	1997-05-17	2000-08-01	Glaxo Group Ltd	Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente
AU769660B2 (en) *	1997-05-17	2004-01-29	Glaxo Group Limited	Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
US6875773B1 (en)	1998-05-29	2005-04-05	Ben M. Dunn	Combination therapy for treatment of FIV infection
CA2374198A1 (fr) *	1998-05-29	1999-12-02	Maki Arai	Therapie combinee pour le traitement des infections dues au vif
GB9820417D0 (en) *	1998-09-18	1998-11-11	Glaxo Group Ltd	Antiviral combinations
US6432966B2 (en)	1999-10-29	2002-08-13	Smithkline Beecham Corporation	Antiviral combinations
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) *	2001-05-11	2011-03-24	Cipla Medpro Pty Ltd	Pharmaceutical composition.
AR040242A1 (es) *	2002-06-04	2005-03-23	Glaxo Group Ltd	Composiciones farmaceuticas
MXPA05007016A (es)	2003-01-14	2005-09-12	Gilead Sciences Inc	Composiciones y metodos para terapia antiviral de combinacion.
BRPI0408704A (pt)	2003-03-24	2006-03-07	Hoffmann La Roche	benzil-piridazinonas como inibidores de transcriptase reversa
EP1692516B1 (fr)	2003-10-24	2010-12-01	Immunaid Pty Ltd	Methode therapeutique
TWI471145B (zh)	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
WO2007045573A1 (fr)	2005-10-19	2007-04-26	F. Hoffmann-La Roche Ag	Phénylacétamides en tant qu'inhibiteurs de nnrt
CN101553483B (zh)	2006-12-13	2013-04-17	弗·哈夫曼-拉罗切有限公司	作为非核苷逆转录酶抑制剂的2-(哌啶-4-基)-4-苯氧基-或苯基氨基-嘧啶衍生物
PL2120878T3 (pl) *	2007-02-09	2015-01-30	Alphapharm Pty Ltd	Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych
WO2010135781A1 (fr)	2009-05-27	2010-12-02	Immunaid Pty Ltd	Procédés de traitement de maladies
PE20121524A1 (es)	2010-01-27	2012-12-03	Viiv Healthcare Co	Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos
HK1220390A1 (zh)	2013-08-29	2017-05-05	Teva Pharmaceutical Industries Ltd.	包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂
CA2942877A1 (fr)	2014-04-08	2015-10-15	Nitzan SHAHAR	Forme pharmaceutique unitaire comprenant de l'emtricitabine, du tenofovir, du darunavir et du ritonavir
EP4578865A3 (fr)	2014-08-12	2025-07-30	Monash University	Promédicaments dirigeant la lymphe
CA2997106C (fr)	2015-09-08	2024-06-04	Monash University	Promedicaments ciblant la lymphe
US11883497B2 (en)	2017-08-29	2024-01-30	Puretech Lyt, Inc.	Lymphatic system-directing lipid prodrugs
EP3675838A4 (fr) *	2017-08-29	2021-04-21	PureTech LYT, Inc.	Promédicaments lipidiques orientant vers le système lymphatique
US11608345B1 (en)	2017-12-19	2023-03-21	Puretech Lyt, Inc.	Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en)	2017-12-19	2022-04-19	Puretech Lyt, Inc.	Lipid prodrugs of mycophenolic acid and uses thereof
CN115348864A (zh)	2020-02-05	2022-11-15	纯技术Lyt股份有限公司	神经甾体的脂质前药

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4724232A (en) *	1985-03-16	1988-02-09	Burroughs Wellcome Co.	Treatment of human viral infections
US5047407A (en)	1989-02-08	1991-09-10	Iaf Biochem International, Inc.	2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en)	1988-06-10	1992-06-16	Regents Of The University Of Minnesota	Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) *	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
US5204466A (en)	1990-02-01	1993-04-20	Emory University	Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) *	1990-05-02	1990-06-27	Glaxo Group Ltd	Chemical compounds
GB9104740D0 (en)	1991-03-06	1991-04-17	Wellcome Found	Antiviral nucleoside combination
WO1992020344A1 (fr) *	1991-05-16	1992-11-26	Glaxo Group Limited	Combinaisons antivirales contenant des analogues de nucleosides
ATE184787T1 (de) *	1992-05-13	1999-10-15	Wellcome Found	Therapeutische kombinationen
US5723490A (en)	1992-09-08	1998-03-03	Vertex Pharmaceuticals Incorporated	THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en)	1994-08-26	1994-10-19	Wellcome Found	A novel salt
US5869461A (en)	1995-03-16	1999-02-09	Yale University	Reducing toxicity of L-nucleosides with D-nucleosides
CZ429398A3 (cs)	1996-06-25	1999-05-12	Glaxo Group Limited	Kombinace účinných látek a farmaceutický prostředek
NZ333099A (en)	1996-06-25	2000-06-23	Glaxo Group Ltd	synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
DE10226522A1 (de)	2002-06-14	2003-12-24	Degussa	Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

1996
- 1996-03-27 MY MYPI96001152A patent/MY115461A/en unknown
- 1996-03-28 US US08/930,225 patent/US6417191B1/en not_active Expired - Lifetime
- 1996-03-28 JP JP8528931A patent/JP2954357B2/ja not_active Expired - Lifetime
- 1996-03-28 DE DE1996622386 patent/DE122005000029I2/de active Active
- 1996-03-28 WO PCT/EP1996/001352 patent/WO1996030025A1/fr not_active Ceased
- 1996-03-28 UA UA97094740A patent/UA60293C2/uk unknown
- 1996-03-28 SK SK1295-97A patent/SK283825B6/sk not_active IP Right Cessation
- 1996-03-28 BR BRPI9607851A patent/BRPI9607851B8/pt unknown
- 1996-03-28 CN CN96194050A patent/CN1103593C/zh not_active Expired - Lifetime
- 1996-03-28 AU AU54972/96A patent/AU715213B2/en not_active Expired
- 1996-03-28 EA EA199700203A patent/EA000626B3/ru not_active IP Right Cessation
- 1996-03-28 DK DK96911953T patent/DK0817637T3/da active
- 1996-03-28 PT PT96911953T patent/PT817637E/pt unknown
- 1996-03-28 AP APAP/P/1997/001089A patent/AP652A/en active
- 1996-03-28 MX MX9707316A patent/MX9707316A/es active IP Right Grant
- 1996-03-28 EE EE9700240A patent/EE04047B1/xx not_active IP Right Cessation
- 1996-03-28 GE GEAP19963898A patent/GEP20022647B/en unknown
- 1996-03-28 BR BRPI9607851-0A patent/BR9607851B1/pt active IP Right Grant
- 1996-03-28 DE DE200512000029 patent/DE122005000029I1/de active Pending
- 1996-03-28 KR KR1019970706824A patent/KR100542536B1/ko not_active Expired - Lifetime
- 1996-03-28 SI SI9630494T patent/SI0817637T1/xx unknown
- 1996-03-28 RO RO97-01795A patent/RO117995B1/ro unknown
- 1996-03-28 EP EP96911953A patent/EP0817637B1/fr not_active Expired - Lifetime
- 1996-03-28 ES ES96911953T patent/ES2179193T3/es not_active Expired - Lifetime
- 1996-03-28 CZ CZ19973090A patent/CZ295940B6/cs not_active IP Right Cessation
- 1996-03-28 TR TR97/01074T patent/TR199701074T1/xx unknown
- 1996-03-28 DE DE69622386T patent/DE69622386T2/de not_active Expired - Lifetime
- 1996-03-28 PL PL96322532A patent/PL187085B1/pl unknown
- 1996-03-28 HU HU9801571A patent/HU224010B1/hu active Protection Beyond IP Right Term
- 1996-03-28 CA CA002216634A patent/CA2216634C/fr not_active Expired - Lifetime
- 1996-03-28 BR BRPI9612992-1A patent/BRPI9612992B1/pt not_active IP Right Cessation
- 1996-03-28 AT AT96911953T patent/ATE220551T1/de active
- 1996-03-28 NZ NZ306419A patent/NZ306419A/xx not_active IP Right Cessation
- 1996-03-29 IL IL11772796A patent/IL117727A/xx not_active IP Right Cessation
1997
- 1997-09-17 OA OA70075A patent/OA10616A/en unknown
- 1997-09-29 NO NO19974510A patent/NO313787B1/no not_active IP Right Cessation
2005
- 2005-05-04 LU LU91171C patent/LU91171I2/fr unknown
- 2005-05-09 NL NL300195C patent/NL300195I2/nl unknown
- 2005-05-09 FR FR05C0022C patent/FR05C0022I2/fr active Active
- 2005-05-24 NO NO2005014C patent/NO2005014I2/no unknown

Also Published As

Publication number	Publication date
MY115461A (en)	2003-06-30
ES2179193T3 (es)	2003-01-16
DK0817637T3 (da)	2002-11-11
LU91171I9 (fr)	2018-12-28
CA2216634C (fr)	2004-07-20
GEP20022647B (en)	2002-03-25
PL187085B1 (pl)	2004-05-31
JPH10511682A (ja)	1998-11-10
CZ309097A3 (cs)	1998-05-13
RO117995B1 (ro)	2002-12-30
HK1009401A1 (en)	1999-09-10
KR100542536B1 (ko)	2006-03-23
AU715213B2 (en)	2000-01-20
BRPI9612992B1 (pt)	2020-08-04
DE122005000029I1 (de)	2005-10-06
CN1103593C (zh)	2003-03-26
NO2005014I2 (no)	2008-02-11
NO313787B1 (no)	2002-12-02
SK283825B6 (sk)	2004-02-03
WO1996030025A1 (fr)	1996-10-03
AP652A (en)	1998-06-19
EE04047B1 (et)	2003-06-16
BRPI9607851B8 (pt)	2019-11-05
NL300195I2 (nl)	2005-11-01
JP2954357B2 (ja)	1999-09-27
DE122005000029I2 (de)	2006-04-27
NO2005014I1 (no)	2005-06-06
NL300195I1 (nl)	2005-08-01
TR199701074T1 (xx)	1998-02-21
MX9707316A (es)	1997-11-29
DE69622386T2 (de)	2003-02-13
DE69622386D1 (de)	2002-08-22
IL117727A0 (en)	1996-07-23
EE9700240A (et)	1998-04-15
EP0817637B1 (fr)	2002-07-17
FR05C0022I2 (fr)	2005-10-21
BR9607851B1 (pt)	2009-01-13
ATE220551T1 (de)	2002-08-15
OA10616A (en)	2001-03-15
CZ295940B6 (cs)	2005-12-14
NZ306419A (en)	2000-01-28
PT817637E (pt)	2002-11-29
NO974510D0 (no)	1997-09-29
EA000626B3 (ru)	2016-04-29
SK129597A3 (en)	1998-07-08
HU224010B1 (hu)	2005-04-28
EP0817637A1 (fr)	1998-01-14
AP9701089A0 (en)	1997-10-31
FR05C0022I1 (fr)	2005-06-10
CA2216634A1 (fr)	1996-10-03
LU91171I2 (fr)	2005-07-04
HUP9801571A2 (hu)	1999-01-28
SI0817637T1 (en)	2002-10-31
US6417191B1 (en)	2002-07-09
NO974510L (no)	1997-09-29
KR19980703420A (ko)	1998-11-05
AU5497296A (en)	1996-10-16
CN1185110A (zh)	1998-06-17
PL322532A1 (en)	1998-02-02
EA199700203A1 (ru)	1998-02-26
EA000626B1 (ru)	1999-12-29
HUP9801571A3 (en)	2001-04-28
BR9607851A (pt)	1998-07-21
UA60293C2 (uk)	2003-10-15

Legal Events

Date	Code	Title	Description
1997-01-10	HK	Corrigendum	Free format text: JOURNAL NO. 4/96 P. 1004, PATENT APPLICATION NO. 117727, ADD FURTHER PRIORITY 9506489.5 30.03.1995GB
2000-06-01	FF	Patent granted
2000-08-31	KB	Patent renewed
2002-05-23	KB	Patent renewed
2007-02-12	EXTF	Application for patent extension filed
2010-10-31	KB	Patent renewed
2014-02-27	KB	Patent renewed
2016-10-31	EXP	Patent expired

Publication	Publication Date	Title
IL117727A0 (en)	1996-07-23	Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them
IL114622A0 (en)	1995-11-27	Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL114626A0 (en)	1995-11-27	6-membered nitrogen-containing heteroaryl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL105218A0 (en)	1993-12-28	Hexanones and pharmaceutical compositions containing them
IL105223A0 (en)	1994-08-26	Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL121236A0 (en)	1998-01-04	Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL117860A0 (en)	1996-08-04	Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL122293A0 (en)	1998-04-05	Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL117349A0 (en)	1996-07-23	N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
AP9701160A0 (en)	1998-01-31	Compounds and pharmaceutical compositions containing them
HU9502918D0 (en)	1995-11-28	Pharmaceutical composition of antihypertriglyceridemic activity
IL117554A0 (en)	1996-07-23	Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL106098A0 (en)	1993-10-20	Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL107653A0 (en)	1994-02-27	N,n-disubstituted arylcycloalkylamines their preparation and pharmaceutical compositions containing them
IL117815A0 (en)	1996-08-04	Ascomycins their preparation and pharmaceutical compositions containing them
IL105135A (en)	2000-01-31	Carbapenems their preparation their use and pharmaceutical compositions containing them
IL116190A (en)	1999-12-22	Eleutherobin, analogs thereof and pharmaceutical compositions containing them
IL119371A0 (en)	1997-01-10	Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL118672A0 (en)	1996-10-16	Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL114623A0 (en)	1995-11-27	Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
GB9501286D0 (en)	1995-03-15	Pharmaceutical compositions and preparations thereof
IL113415A (en)	1999-11-30	Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
IL106290A0 (en)	1993-11-15	Enzyme inhibitors,their preparation and pharmaceutical compositions containing them
IL111216A0 (en)	1994-12-29	Heteroarylpiperidines, their preparation and pharmaceutical compositions containing them
IL115982A (en)	1999-10-28	Cyclolignan derivatives and pharmaceutical compositions containing them